Effect of somatostatin on blood glucose, plasma growth hormone, insulin, and free fatty acids in normal subjects and acromegalic patients

M. Peracchi, E. Reschini, L. Cantalamessa, G. Giustina, F. Cavagnini, M. Pinto, P. Bulgheroni

Research output: Contribution to journalArticle

Abstract

Synthetic growth-hormone-release inhibitory hormone (GRIH, somatostatin) infused in seven acromegalics significantly lowered plasma growth hormone (GH) and immunoreactive insulin (IRI) levels, did not have any effect on blood glucose, and significantly increased plasma free fatty acids (FFA). Somatostatin, when infused in three normal subjects during an arginine test, inhibited plasma GH and IRI responses. Hypoglycemia-induced GH release was also blocked by somatostatin in two normal subjects thus tested.

Original languageEnglish
Pages (from-to)1009-1015
Number of pages7
JournalMetabolism
Volume23
Issue number11
DOIs
Publication statusPublished - 1974

Fingerprint

Somatostatin
Nonesterified Fatty Acids
Growth Hormone
Blood Glucose
Insulin
Hypoglycemia
Arginine
Hormones

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Effect of somatostatin on blood glucose, plasma growth hormone, insulin, and free fatty acids in normal subjects and acromegalic patients. / Peracchi, M.; Reschini, E.; Cantalamessa, L.; Giustina, G.; Cavagnini, F.; Pinto, M.; Bulgheroni, P.

In: Metabolism, Vol. 23, No. 11, 1974, p. 1009-1015.

Research output: Contribution to journalArticle

Peracchi, M. ; Reschini, E. ; Cantalamessa, L. ; Giustina, G. ; Cavagnini, F. ; Pinto, M. ; Bulgheroni, P. / Effect of somatostatin on blood glucose, plasma growth hormone, insulin, and free fatty acids in normal subjects and acromegalic patients. In: Metabolism. 1974 ; Vol. 23, No. 11. pp. 1009-1015.
@article{f284e6491fba4d48a785f686d6711a65,
title = "Effect of somatostatin on blood glucose, plasma growth hormone, insulin, and free fatty acids in normal subjects and acromegalic patients",
abstract = "Synthetic growth-hormone-release inhibitory hormone (GRIH, somatostatin) infused in seven acromegalics significantly lowered plasma growth hormone (GH) and immunoreactive insulin (IRI) levels, did not have any effect on blood glucose, and significantly increased plasma free fatty acids (FFA). Somatostatin, when infused in three normal subjects during an arginine test, inhibited plasma GH and IRI responses. Hypoglycemia-induced GH release was also blocked by somatostatin in two normal subjects thus tested.",
author = "M. Peracchi and E. Reschini and L. Cantalamessa and G. Giustina and F. Cavagnini and M. Pinto and P. Bulgheroni",
year = "1974",
doi = "10.1016/0026-0495(74)90067-5",
language = "English",
volume = "23",
pages = "1009--1015",
journal = "Metabolism: Clinical and Experimental",
issn = "0026-0495",
publisher = "W.B. Saunders Ltd",
number = "11",

}

TY - JOUR

T1 - Effect of somatostatin on blood glucose, plasma growth hormone, insulin, and free fatty acids in normal subjects and acromegalic patients

AU - Peracchi, M.

AU - Reschini, E.

AU - Cantalamessa, L.

AU - Giustina, G.

AU - Cavagnini, F.

AU - Pinto, M.

AU - Bulgheroni, P.

PY - 1974

Y1 - 1974

N2 - Synthetic growth-hormone-release inhibitory hormone (GRIH, somatostatin) infused in seven acromegalics significantly lowered plasma growth hormone (GH) and immunoreactive insulin (IRI) levels, did not have any effect on blood glucose, and significantly increased plasma free fatty acids (FFA). Somatostatin, when infused in three normal subjects during an arginine test, inhibited plasma GH and IRI responses. Hypoglycemia-induced GH release was also blocked by somatostatin in two normal subjects thus tested.

AB - Synthetic growth-hormone-release inhibitory hormone (GRIH, somatostatin) infused in seven acromegalics significantly lowered plasma growth hormone (GH) and immunoreactive insulin (IRI) levels, did not have any effect on blood glucose, and significantly increased plasma free fatty acids (FFA). Somatostatin, when infused in three normal subjects during an arginine test, inhibited plasma GH and IRI responses. Hypoglycemia-induced GH release was also blocked by somatostatin in two normal subjects thus tested.

UR - http://www.scopus.com/inward/record.url?scp=0016267588&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016267588&partnerID=8YFLogxK

U2 - 10.1016/0026-0495(74)90067-5

DO - 10.1016/0026-0495(74)90067-5

M3 - Article

C2 - 4418535

AN - SCOPUS:0016267588

VL - 23

SP - 1009

EP - 1015

JO - Metabolism: Clinical and Experimental

JF - Metabolism: Clinical and Experimental

SN - 0026-0495

IS - 11

ER -